文献速递产科

交叉征对剖宫产瘢痕妊娠女性超声引导下负压吸引术结局的预测价值

Predictive value of crossover sign for outcome of ultrasound-guided vacuum aspiration in women with Cesarean scar pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-02-26

回顾性队列研究纳入181例剖宫产瘢痕妊娠(CSP)女性,按交叉征(COS)分型为COS-1(90例)与COS-2(91例),分析超声引导下负压吸引术结局。COS-1组治疗失败率25.6%高于COS-2组8.8%(P=0.003),COS-1及大孕囊为治疗失败独立危险因素。

要点

  • COS-1组治疗失败率25.6%,高于COS-2组的8.8%(P=0.003)。
  • COS-1组妊娠组织残留率18.9%,高于COS-2组的6.6%(P=0.013)。
  • COS-1组二次治疗率20.0%,高于COS-2组的6.6%(P=0.002)。

核心结论

  • 超声评估孕囊与子宫内膜线关系(COS分型)可能有助于预测CSP患者负压吸引术的治疗结局。
  • 作者认为COS-1患者、尤其孕囊直径>30.0 mm者,可能不宜行负压吸引术。

研究设计与样本

  • 回顾性队列研究,纳入181例接受超声引导下负压吸引术的CSP女性。
  • 按孕囊、剖宫产瘢痕与子宫前壁关系将CSP分为COS-1(90例,49.7%)与COS-2(91例,50.3%)。

主要发现

  • COS-1组治疗失败率25.6%,高于COS-2组的8.8%(P=0.003)。
  • COS-1组妊娠组织残留率18.9%,高于COS-2组的6.6%(P=0.013)。
  • COS-1组二次治疗率20.0%,高于COS-2组的6.6%(P=0.002)。
  • COS-1组出血≥200 mL发生率13.3%,高于COS-2组的4.4%(P=0.034)。
  • COS-1与孕囊直径30.1-50.0 mm、>50.0 mm均独立关联治疗失败风险升高(OR分别为4.57(95%CI 1.66-12.56;P=0.003)、4.34(95%CI 1.35-13.94;P=0.014)、10.50(95%CI 2.54-43.46;P=0.001))。

关键数值与推荐

  • COS-1组治疗失败率25.6% vs COS-2组8.8%(P=0.003)。
  • COS-1组妊娠组织残留率18.9% vs COS-2组6.6%(P=0.013)。
  • COS-1组二次治疗率20.0% vs COS-2组6.6%(P=0.002)。
  • COS-1组出血≥200 mL发生率13.3% vs COS-2组4.4%(P=0.034)。
  • COS-1的OR 4.57(95%CI 1.66-12.56;P=0.003);孕囊直径30.1-50.0 mm的OR 4.34(95%CI 1.35-13.94;P=0.014);孕囊直径>50.0 mm的OR 10.50(95%CI 2.54-43.46;P=0.001)。

临床怎么用

  • 作者认为对CSP患者行超声COS分型可能有助于预测负压吸引术结局。
  • 作者认为COS-1患者、尤其孕囊直径>30.0 mm者,可能不宜行负压吸引术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the value of the crossover sign (COS) in predicting treatment outcome in women with a Cesarean scar pregnancy (CSP) who were treated with ultrasound-guided vacuum aspiration. METHODS: This was a retrospective cohort study of women with CSP who underwent ultrasound-guided vacuum aspiration. Based on the relationship between the gestational sac, Cesarean scar and anterior wall of the uterus, CSPs were classified by COS type. Analysis was conducted to investigate the association between COS type (COS-1, COS-2) and treatment outcome. The incidence of treatment failure, retained pregnancy tissue, secondary therapy and bleeding ≥ 200 mL were analyzed. RESULTS: In total, 181 eligible patients with CSP, including 90 (49.7%) women with COS-1 and 91 (50.3%) women with COS-2, were analyzed. COS-1 patients had a higher incidence of treatment failure compared with COS-2 patients (25.6% vs 8.8%; P = 0.003), as well as higher rates of retained pregnancy tissue (18.9% vs 6.6%; P = 0.013), secondary therapy (20.0% vs 6.6%; P = 0.002) and bleeding of ≥ 200 mL (13.3% vs 4.4%; P = 0.034). COS-1 and a large gestational sac (30.1-50.0 mm or >50.0 mm in diameter) were associated independently with increased risk of treatment failure (odds ratio, 4.57 (95% CI, 1.66-12.56); P = 0.003, 4.34 (95% CI, 1.35-13.94); P = 0.014 and 10.50 (95% CI, 2.54-43.46); P = 0.001, respectively). CONCLUSIONS: Ultrasound evaluation of the relationship between the gestational sac and the endometrial line (COS classification) in women with CSP may help to predict treatment outcome among those undergoing vacuum aspiration. Among COS-1 patients, especially those with a gestational sac diameter of >30.0 mm, vacuum aspiration may be discouraged. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Shen M, Li L, Zhu L, et al. Predictive value of crossover sign for outcome of ultrasound-guided vacuum aspiration in women with Cesarean scar pregnancy. Ultrasound Obstet Gynecol. 2024. PMID: 37610656. doi:10.1002/uog.27459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。